Home / Share Price Target / Ipcalab
Ipca Labs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Ipca Laboratories Limited | |||
Symbol: IPCALAB | |||
Price: ₹1,478.09 | |||
Exchange: NSE | |||
Healthcare -> Drug Manufacturers—Specialty & Generic |
Show Table of Contents
Table of Contents
- 1: Ipca Labs Brief Company Overview
- 1.1: Ipca Labs Financial Performance
- 1.1.1: Is Ipca Labs A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Ipca Labs Share Price Target For 2024
- 2.1.1: Ipca Labs Share Price Target Table For 2024
- 2.1.2: Summary: Ipca Labs Share Price Prediction For 2024
- 2.2: Ipca Labs Share Price Target For 2025
- 2.2.1: Ipca Labs Share Price Target Table For 2025
- 2.2.2: Summary: Ipca Labs Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Ipca Labs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Ipca Labs Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Ipca Labs Past Performance
Ipca Labs Brief Company Overview
**Company Overview**
Established in 1949, Ipca Laboratories is a leading pharmaceutical company in India. They manufacture and market pharmaceutical formulations and active pharmaceutical ingredients (APIs) for diverse therapeutic segments.
**Key Products and Services**
Ipca's product portfolio includes:
- Generic and branded formulations
- APIs in areas like anti-hypertensive, anti-malarial, and anti-diabetic
**Diverse Product Range**
Their therapeutic segments cover a wide range, including:
- Allergy
- Cardiology
- Neurology
- Ophthalmology
- Respiratory diseases
**Reputation and Commitment**
Ipca Laboratories has a strong reputation in the industry for its commitment to quality and innovation.
Advertisement
Ipca Labs Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 36,397.64 Crore | Market valuation of Ipca Labs's shares. |
Revenue (TTM) | 8,213.3 Crore | Total revenue generated by Ipca Labs over the past twelve months. |
Net Income (TTM) | +576.76 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 14.04% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 7.02% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +31.8% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +18.09% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 18.61 | Company's total debt divided by total shareholder equity. |
Total Debt | 1,438.35 Crore | Sum of Ipca Labs's current & long-term financial obligations. |
Total Cash | 854.26 Crore | Total amount of liquid funds available to Ipca Labs. |
Beta | 0.23 | Beta is less than 1 indicating that the Ipca Labs's price is less volatile than the market. |
Is Ipca Labs A Good Buy For Long Term?
Ipca Labs is showing strong growth with a 69.22% return over the past year and a 35.05% return over the past three years. While the current debt level of 1,438.35 Crore is a factor to consider, the company's healthy cash balance of 854.26 Crore and positive profit margin of 7.02% suggest good financial health. The consistent growth and strong fundamentals make Ipca Labs a good buy for long-term investors seeking a potential value play in the pharmaceutical sector.
To predict the Ipca Labs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Ipca Labs Share Price Target For 2024
The line chart displays the monthly closing prices of Ipca Labs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ipca Labs shares in 2024, see the table below.
Advertisement
Ipca Labs Share Price Target Table For 2024
Ipca Labs's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 1553.38 (+5.09%) | Price Action: Chart |
2024 Target 2 | 1524.42 (+3.13%) | Custom Fibonacci Extension Lvl 23.6% |
2024 Target 1 | 1509.00 (+2.09%) | Price Action: 24 Sep 2024 High |
Current Price | 1478.09 | Ipca Labs's 1 share price as of Fri 27 Sep 2024 |
Stop Loss 1 | 1462.94 (-1.03%) | Price Action: 12 Sep 2024 High |
Stop Loss 2 | 1448.15 (-2.03%) | Price Action: 10 Sep 2024 High |
Stop Loss 3 | 1431.94 (-3.13%) | Price Action: 23 Sep 2024 Low |
Summary: Ipca Labs Share Price Prediction For 2024
In summary, Ipca Labs has surged by ₹364.94, achieving a notable +32.78% increase from 1st January 2024 to 27 Sep 2024. Our analysis of Ipca Labs for 2024 predicts an additional rise of 2.09% to 5.09% by the end of 2024 with three potential targets T1: 1509.00, T2: 1524.42, T3: 1553.38. Stop Loss at SL1: 1462.94, SL2: 1448.15, SL3: 1431.94.
Ipca Labs has a 52-week high of ₹1519.84, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹897.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Ipca Labs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Ipca Labs Share Price Target For 2025
The line chart displays the monthly closing prices of Ipca Labs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ipca Labs shares in 2025, see the table below.
Advertisement
Ipca Labs Share Price Target Table For 2025
Ipca Labs's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 2027.55 (+37.17%) | Fibonacci Extension Level 171.8% |
2025 Target 2 | 1985.07 (+34.29%) | Price Action: Chart |
2025 Target 1 | 1965.42 (+32.97%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 1478.09 | Ipca Labs's 1 share price as of Fri 27 Sep 2024 |
Stop Loss 1 | 1366.00 (-7.59%) | Price Action: Aug 2024 Low |
Stop Loss 2 | 1332.15 (-9.88%) | Price Action: Aug 2021 High |
Stop Loss 3 | 1292.09 (-12.59%) | Price Action: Jul 2024 Low |
Summary: Ipca Labs Share Price Prediction For 2025
In summary, Ipca Labs has surged by ₹364.94, achieving a notable +32.78% increase from 1st January 2024 to 27 Sep 2024. Our analysis of Ipca Labs for 2025 predicts an additional rise of 32.97% to 37.17% by the end of 2025 with three potential targets T1: 1965.42, T2: 1985.07, T3: 2027.55. Stop Loss at SL1: 1366.00, SL2: 1332.15, SL3: 1292.09.
Ipca Labs has a All-Time high of ₹1519.84, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹897.50, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Ipca Labs, we have created a specific page for that check here: Ipca Labs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Ipca Labs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Ipca Labs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 12.14% over the next 15 years.
For complete year by year Ipca Labs long term share price target from 2024, 2025 to 2039 check the below table.
Ipca Labs Share Price Target Table From 2024, 2025, 2026 to 2039
Year | Ipca Labs Target | YoY Change % |
---|---|---|
2024 | ₹1,478.09 | [Current Price] |
2024 | ₹1,580.01 | 6.89% |
2025 | ₹2,014.6 | 27.5% |
2026 | ₹2,307.46 | 14.53% |
2027 | ₹2,712.89 | 17.56% |
2028 | ₹3,164.74 | 16.65% |
2029 | ₹3,690.63 | 16.61% |
2030 | ₹4,138.35 | 12.13% |
2031 | ₹4,316.41 | 4.3% |
2032 | ₹4,724.52 | 9.45% |
2033 | ₹5,208.35 | 10.24% |
2034 | ₹5,801.26 | 11.38% |
2035 | ₹6,262.11 | 7.94% |
2036 | ₹6,325.36 | 1.01% |
2037 | ₹6,736.16 | 6.49% |
2038 | ₹7,251.97 | 7.65% |
2039 | ₹7,854.93 | 8.31% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Ipca Labs Past Performance
- In 1994, Ipca Labs opening price was ₹19.88
- As of Fri 27 Sep 2024 the price stands at ₹1,478.09.
- This represents a Compound Annual Growth Rate (CAGR) of 14.91%.
- In 30 years, an investment of 10,000 would have become ₹7.43 Lakh.
As we wrap up, we hope you like our study on Ipca Labs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Ipca Labs Share Price History
- Ipca Labs Price Target Tomorrow
- Ipca Labs Dividend History
- Ipca Labs Bonus History
- Ipca Labs Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.